Scorecard
| Current Price | Overvalued | |
| Yield (%) – Higher is better Current Yield: 2.45% Industry Average: 2.74% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 5.81% Industry Average: 6.42% | ||
| Returns (%) – Higher is better Returns: 29.70% Industry Average: 23.51% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 67.05% Industry Average: 51.70 | ||
ABBVIE INC.
(XNYS:ABBV)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 282.79 | $ -2.63 |
Dividend
Annual Dividend | Annual Yield |
$ 6.92 | 2.45 % |
Dividend Streak | 5 Year Average |
13 year(s) | 3.82 % |
Fair Price
Current Stock price is considered: Overvalued
| Current Price ● $ 282.79 |
| Less Than $154.17 | $154.17 – $209.49 | More Than $209.49 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
5.81 % | 5.17 % | 6.83 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 5.20 | $ 5.64 | $ 5.92 | $ 6.20 | $ 6.56 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 64.75 29.70 % | $ 168.12 | 19.79 % |